Clinical Trial Update: Prospective Phase II Clinical Study of Neoadjuvant Chemoradiotherapy Combined With PD-1/PD-L1 Inhibitors in the Treatment of Locally Advanced Resectable Esophageal Squamous Cell Carcinoma [Phase 2]

View source ↗

Summary

This document describes a prospective Phase II study evaluating neoadjuvant chemoradiotherapy combined with PD-1/PD-L1 inhibitors for locally advanced, resectab…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Squamous Cell Carcinoma

Snippet

Sponsor: Henan Cancer Hospital | Conditions: Esophageal Malignant Neoplasm Primary | Phase 2 | Status: ACTIVE_NOT_RECRUITING